hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis

被引:29
|
作者
Han, Fengjiao [1 ]
Zhong, Chaoqin [1 ,2 ]
Li, Wei [1 ]
Wang, Ruiqing [1 ]
Zhang, Chen [1 ]
Yang, Xinyu [1 ]
Ji, Chunyan [1 ]
Ma, Daoxin [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China
[2] Yantai Mt Hosp, Dept Hematol, Yantai 264000, Peoples R China
基金
中国国家自然科学基金;
关键词
AML; biomarker; circRNAs; CREBRF; hsa_circ_0001947; hsa-miR-329-5p; therapy; CIRCULAR RNAS; GASTRIC-CANCER; CELL-GROWTH; IDENTIFICATION; CREBRF; SPONGE; GENE; ACTS;
D O I
10.2217/epi-2019-0352
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear. Therefore, we aimed to define novel circRNAs involved the development and progression of AML. Materials & methods: We used circRNAs microarray to determine the differential expression profile. Quantitative reverse transcription PCR analyzed the expression of hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947in vitro and in vivo. A dual-luciferase and mimics/inhibitor were to determine the target gene relationship. Results:hsa_circ_0001947 functions as a tumor inhibitor to suppress AML cell proliferation through hsa-miR-329-5p/CREBRF axis. Conclusion:hsa_circ_0001947 may be as a novel potential biomarker for the treatment of AML.
引用
下载
收藏
页码:935 / 953
页数:19
相关论文
共 50 条
  • [31] Hsa_circ_0037897 may be a risk factor for essential hypertension via hsa-miR-145-5p
    Tao, Zhenbo
    Zheng, Shuying
    He, Xin
    Sun, Jihan
    He, Canxia
    Zhang, Lina
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2021, 43 (03) : 281 - 286
  • [32] Hsa_circ_0004662 Accelerates the Progression of Osteoarthritis via the microRNA-424-5p/VEGFA Axis
    Xie, Wei
    Jiang, Luoyong
    Huang, Xiaoyang
    You, Wei
    Sun, Wei
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 217 - 225
  • [33] Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR-578/EPSTI1 axis
    Zeng, Xuehui
    Zheng, Qingqi
    Wang, Lang
    Chen, Tao
    Lin, Wenxin
    Lin, Quanyang
    THORACIC CANCER, 2023, 14 (26) : 2665 - 2677
  • [34] Hsa_circ_0021205 enhances lipolysis via regulating miR-195-5p/HSL axis and drives malignant progression of glioblastoma
    Suwen Li
    Jiaqi Yuan
    Zhe Cheng
    Yongdong Li
    Shan Cheng
    Xinglei Liu
    Shilu Huang
    Zhipeng Xu
    Anyi Wu
    Liang Liu
    Jun Dong
    Cell Death Discovery, 10
  • [35] Research Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis
    Ji, Changle
    Hu, Jiashu
    Wang, Xuehui
    Zheng, Wenfang
    Deng, Xiaochong
    Song, Hongming
    Yu, Yunhe
    Luo, Qifeng
    Hua, Kaiyao
    Zhou, Xiqian
    Fang, Lin
    AGING-US, 2021, 13 (07): : 9627 - 9645
  • [36] Hsa_circ_0021205 enhances lipolysis via regulating miR-195-5p/HSL axis and drives malignant progression of glioblastoma
    Li, Suwen
    Yuan, Jiaqi
    Cheng, Zhe
    Li, Yongdong
    Cheng, Shan
    Liu, Xinglei
    Huang, Shilu
    Xu, Zhipeng
    Wu, Anyi
    Liu, Liang
    Dong, Jun
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [37] Identification of a Novel hsa_circ_0058058/miR-324-5p Axis and Prognostic/Predictive Molecules for Acute Myeloid Leukemia Outcome by Bioinformatics-Based Analysis
    Misir, Sema
    Ozer Yaman, Serap
    Petrovic, Nina
    Sami, Ahmad
    Akidan, Osman
    Hepokur, Ceylan
    Aliyazicioglu, Yuksel
    BIOLOGY-BASEL, 2024, 13 (07):
  • [38] Hsa _circ_0002060 Knockdown Ameliorates Osteoporosis by Targeting MiR-198-5p
    Liu, Man
    Meng, Yao
    He, Keren
    Luan, Chonglin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (01) : 88 - 95
  • [39] Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p
    Xia, Fada
    Chen, Yong
    Jiang, Bo
    Bai, Ning
    Li, Xinying
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [40] Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p
    Fada Xia
    Yong Chen
    Bo Jiang
    Ning Bai
    Xinying Li
    Cancer Cell International, 20